Greatmark Investment Partners, Inc. Pfizer Inc Transaction History

Greatmark Investment Partners, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $25,672 - $30,008	-800 Reduced 11.55%	6,127 $203,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $18,060 - $20,895	500 Added 7.78%	6,927 $254,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $64,546 - $78,794	-1,475 Reduced 18.67%	6,427 $281,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $26,754 - $31,722	575 Added 7.85%	7,902 $414,000
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $64,050 - $79,366	1,400 Added 23.62%	7,327 $379,000
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $4,132 - $6,125	-100 Reduced 1.66%	5,927 $350,000
Q2 2021 Aug 23, 2021	SELL	$35.91 - $40.68 $111,320 - $126,108	-3,100 Reduced 33.97%	6,027 $236,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $103,890 - $132,106	3,104 Added 51.54%	9,127 $336,000
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $191,230 - $224,356	6,023 New	6,023 $221,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $152,395 - $217,739	-5,638 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $32,920 - $37,360	-1,000 Reduced 15.06%	5,638 $221,000
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $53,858 - $61,404	-1,400 Reduced 17.42%	6,638 $290,000
Q3 2018 Oct 31, 2018	BUY	$34.47 - $41.81 $82,728 - $100,344	2,400 Added 42.57%	8,038 $354,000
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $36,419 - $38,642	-1,095 Reduced 16.26%	5,638 $204,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $208,723 - $229,931	6,733	6,733 $240,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.